Bio Essence Corp
BIOE · OTCMCIK 1723059fmd_0BKESNDABN2JAR740M7H1H60SXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 1 | 1 | 0 | 2 |
| Cost of revenue | 1 | 1 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 1 |
| Total operating expenses | 1 | 1 | 1 | 0 | 1 | 1 |
| Operating income | (1) | (1) | (1) | (0) | (0) | 1 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | (1) | (0) |
| Income before taxes | (1) | (1) | (1) | (0) | (2) | 1 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (1) | (1) | (1) | (0) | (2) | 1 |
| Net income | (1) | (1) | (1) | (1) | (1) | 1 |